AYTUNasdaqPharmaceutical Preparations

Aytu Biopharma, Inc (AYTU) earnings date, market-implied expected move, and options open interest by expiry

1.94

0.00 · 0.00%

Closed16:00 ET

Open1.94Volume9,903Mkt cap$21.0MEPS-1.16

Day1.94 – 1.9450%52-wk1.80 – 3.0711%

AYTU

Aytu Biopharma, Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 10

after close · in 6 days

est.Q1 FY27

Calendar

Next report

Last report

+2.24%

shaded = implied · ▲▼ = realized

Sep 22 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+112.58%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

35 managers

Top fund weight

0.00%

AYTU weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Aytu Biopharma (AYTU) is expected to report on Nov 10 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Sep 22 '26Sep 22 '26confirmed—▲+2.24%—

quarterimplied−5%0+5%realized×

Sep '26—▲+2.24%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

derived from FYQ4 FY26

−0.09%derived from FYnet margin · revenue +29.77% QoQ · +6.42% YoY

Revenue$16M+29.77%

Gross profit$10M64.63%+36.98%

Operating income−$777,000−4.82%+80.88%

Pre-tax income−$4,000+99.93%

Net income−$15,000−0.09%+99.73%

Cost of revenue$6M+18.39%

Operating expenses$11M−4.09%

Tax$11,000+10.00%

Other income$773,000+150.06%

Derived: FY − Q1–Q3 · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

GDP ×1.52· ±4.1% vs ±2.7% · 19 releases

eventrelease day|move|up · n×base

GDPgross domestic product±4.1%7 of 19×1.52

PCEpersonal income & outlays±3.5%7 of 19×1.30

CPROFcorporate profits±3.0%3 of 12×1.09

PPIproducer prices±2.4%5 of 10×0.89

CPIconsumer prices±2.2%1 of 10×0.82

NFPjobs report±2.2%4 of 10×0.80

FOMCrate decision±2.2%8 of 24×0.80

Bar = avg |move| to ±5% · tick = ±2.7% avg day · ×base = |move| ÷ ±2.7% · min 6 releases

Earnings history

EPS 0.21 · consensus —

Quarter	Reported	EPS	Consensus
Q4 FY26	—	0.21	—
Q3 FY26	—	-0.53	—
Q2 FY26	—	-1.05	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod